|
AU2016201801A1
|
|
Treatment of excessive neovascularization
|
|
AU2016200809A1
|
|
Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
|
|
AU2015202378A1
|
|
Repair and/or reconstitution of invertebral discs
|
|
AU2015200657A1
|
|
Perivascular mesenchymal precursor cells
|
|
AU2014200774A1
|
|
Treatment of excessive neovascularization
|
|
CA2893951A1
|
|
Methods of treating or preventing respiratory conditions
|
|
EP3556850A1
|
|
Treatment of diseases of endothelial dysfunction and inflammation
|
|
AU2013203054A1
|
|
Methods of generating, repairing and/or maintaining connective tissue in vivo
|
|
AU2013202303A1
|
|
Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
|
|
WO2013033777A1
|
|
Methods for increasing osteoblastic function
|
|
EP3653218A1
|
|
Methods of treating or preventing rheumatic disease
|
|
CN103841983A
|
|
Methods of treating or preventing neurological diseases
|
|
CA2837898A1
|
|
Method of treating the effects of stroke
|
|
CN103619342A
|
|
Methods for treating obesity and/or metabolic syndrome
|
|
AU2011253969A1
|
|
Perivascular mesenchymal precursor cells
|
|
AU2011253659A1
|
|
Mesenchymal precursor cell
|
|
AU2011253681A1
|
|
Perivascular mesenchymal precursor cell induced blood vessel formation
|
|
AU2011224061A1
|
|
Method of enhancing proliferation and/or survival of Mesenchymal Precursor Cells (MPC)
|
|
CN103800370A
|
|
Method for treating or preventing a pancreatic dysfunction
|
|
KR20190135573A
|
|
Methods of generating, repairing and/or maintaining connective tissue in vivo
|
